Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma
Condition: Uveal Melanoma Interventions: Drug: PAC-1; Drug: Entrectinib Sponsors: Arkadiusz Z. Dudek, MD; HealthPartners Regions Cancer Care and Frauenshuh Cancer Care Centers; Vanquish Oncology, Inc.; Genentech, Inc.; Midwest Melanoma Partnership Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Eye Cancers | Melanoma | Partnerships | Research | Skin Cancer | Study | Uveal Melanoma